Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.152
-0.018 (-1.54%)
Nov 21, 2024, 11:50 AM EST - Market open
Unity Biotechnology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Unity Biotechnology stock has a target of 8.00, which predicts an increase of 594.44% from the current stock price of 1.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 8, 2024.
Analyst Ratings
The average analyst rating for UBX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +594.44% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +594.44% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +594.44% | Apr 16, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +768.06% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.01M
EPS This Year
-1.52
from -2.70
EPS Next Year
-1.76
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 2.1M | 28.0M | ||
| Avg | n/a | 1.0M | 21.0M | ||
| Low | n/a | n/a | 10.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 2,674.5% | ||
| Avg | - | - | 1,981.6% | ||
| Low | - | - | 967.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.56 | -1.80 | -0.62 | ||
| Avg | -1.52 | -1.76 | -0.87 | ||
| Low | -1.49 | -1.74 | -1.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.